US 11066479
Monoclonal antibodies targeting glypican-2 (GPC2) and use thereof
granted A61KA61K2039/505A61K47/6415
Quick answer
US patent 11066479 (Monoclonal antibodies targeting glypican-2 (GPC2) and use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 45
- CPC classes
- A61K, A61K2039/505, A61K47/6415, A61K47/6851, A61K47/6929